We are live on
!
Find out more
TSS
Two Sigma Securities Portfolio holdings
AUM
$861M
1-Year Est. Return
21.33%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$754M
AUM Growth
-$5.17B
(-87%)
Cap. Flow
-$5.32B
Cap. Flow
% of AUM
-705.37%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
3,525
New
760
Increased
256
Reduced
520
Closed
1,976
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$8.37M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.57M |
| 3 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$6.57M |
| 4 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$6.37M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$31.9M |
| 2 |
Apple
AAPL
|
+$30.9M |
| 3 |
Microsoft
MSFT
|
+$25.9M |
| 4 |
Nike
NKE
|
+$24M |
| 5 |
NVIDIA
NVDA
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.83% |
| 2 | Consumer Discretionary | 8.98% |
| 3 | Financials | 6.13% |
| 4 | Industrials | 5.18% |
| 5 | Healthcare | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Galectin Therapeutics
GALT
$200M
| $36.9K | ﹤0.01% |
+28,571
| New | +$68.5K |
|
|
XNET
1227
Xunlei
XNET
$343M
| $35.6K | ﹤0.01% |
+17,905
| New | +$36.3K |
|
|
RVNC
1228
DELISTED
Revance Therapeutics, Inc.
RVNC
| $35.4K | ﹤0.01% |
+11,657
| New | +$50.8K |
|
|
ELEV
1229
DELISTED
Elevation Oncology
ELEV
| $35.1K | ﹤0.01% |
+62,380
| New | +$36.8K |
|
|
ORGN
1230
DELISTED
Origin Materials
ORGN
| $34.3K | ﹤0.01% |
+893
| New | +$33.9K |
|
1231
CALL
Agilon Health
AGL
$1.57B
| $34.2K | ﹤0.01% |
720
-436
| -38% | -$26.4K |
|
|
QNRX
1232
Quoin Pharmaceuticals
QNRX
$8.94M
| $34.2K | ﹤0.01% |
1,501
+591
| +65% | +$13.6K |
|
|
NXDR
1233
Nextdoor Holdings
NXDR
$866M
| $33.9K | ﹤0.01% |
+14,307
| New | +$35.5K |
|
1234
Rockwell Medical
RMTI
$28.5M
| $33.2K | ﹤0.01% |
+1,628
| New | +$47.5K |
|
1235
Community Health Systems
CYH
$412M
| $33.2K | ﹤0.01% |
+11,089
| New | +$46.6K |
|
1236
Wrap Technologies
WRAP
$106M
| $33K | ﹤0.01% |
+15,574
| New | +$25.6K |
|
1237
Smith Micro Software
SMSI
$14.8M
| $32.6K | ﹤0.01% |
4,982
-6,535
| -57% | -$30.2K |
|
|
NVNI
1238
Nvni Group
NVNI
$12.6M
| $32.3K | ﹤0.01% |
+1,319
| New | +$16.6K |
|
1239
Televisa
TV
$1.48B
| $31.7K | ﹤0.01% |
18,886
-28,589
| -60% | -$62K |
|
|
HIVE
1240
HIVE Digital Technologies
HIVE
$791M
| $31.7K | ﹤0.01% |
11,129
+897
| +9% | +$3.36K |
|
|
ZOM
1241
DELISTED
Zomedica Corp.
ZOM
| $31.6K | ﹤0.01% |
+263,323
| New | +$33.2K |
|
|
CANF
1242
Can-Fite BioPharma American Depositary Shares
CANF
$6.79M
| $31.5K | ﹤0.01% |
970
-509
| -34% | -$20.6K |
|
1243
Clean Energy Fuels
CLNE
$410M
| $31.5K | ﹤0.01% |
+12,542
| New | +$35.6K |
|
|
IMDX
1244
Insight Molecular Diagnostics
IMDX
$162M
| $31.5K | ﹤0.01% |
+13,215
| New | +$35.9K |
|
|
MYND
1245
Mynd.ai
MYND
$18.9M
| $31.4K | ﹤0.01% |
+15,725
| New | +$26.5K |
|
|
LMFA
1246
DELISTED
LM Funding America
LMFA
| $31.4K | ﹤0.01% |
+584
| New | +$40.2K |
|
|
ZTEK
1247
Zentek
ZTEK
$85.3M
| $31.1K | ﹤0.01% |
+33,128
| New | +$29.8K |
|
|
TPIC
1248
DELISTED
TPI Composites
TPIC
| $30.6K | ﹤0.01% |
+16,208
| New | +$45K |
|
1249
ECARX Holdings
ECX
$428M
| $30.5K | ﹤0.01% |
+14,432
| New | +$26.6K |
|
1250
Standard BioTools
LAB
$339M
| $30.3K | ﹤0.01% |
+17,341
| New | +$32.3K |
|
Similar funds
BCM
OAM
NOCM
QIM
RB
OMG
MCM
NEPWA
Two Sigma Securities's Q4 2024 Portfolio in Review
As of Q4 2024, Two Sigma Securities held 3,525 positions worth $754M, down 87% from $5.92B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Securities withdrew a net $5.32B in Q4 2024, closing 1,976 positions and reducing 520 holdings. Its most notable exit was Nike, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Two Sigma Securities opened a new position in iShares Core S&P 500 ETF worth $8.32M.
- Two Sigma Securities's largest Q4 2024 buy was iShares Core S&P 500 ETF: 14,140 shares worth $8.32M.
- Two Sigma Securities added most to iShares 20+ Year Treasury Bond ETF in Q4 2024, an estimated $6.57M increase.
- Two Sigma Securities's biggest Q4 2024 reduction was Tesla, cutting an estimated $31.9M.
- Two Sigma Securities fully exited Nike in Q4 2024, selling an estimated $24M.
- Two Sigma Securities's ten largest holdings make up 14% of its $754M portfolio in Q4 2024.
- Two Sigma Securities opened 760 new positions and closed 1,976 in Q4 2024.
- Two Sigma Securities's portfolio value fell 87% quarter-over-quarter to $754M.
Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.